FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149285411> ?p ?o ?g. }

• W2149285411 endingPage "111" @default.
• W2149285411 startingPage "107" @default.
• W2149285411 abstract "Abstract Despite excellent short-term results, long-term survival of transplanted kidneys has not improved accordingly. Although alloimmune responses and calcineurin inhibitor-related nephrotoxicity have been identified as main drivers of fibrosis, no effective treatment options have emerged. In this perspective, mesenchymal stromal cells (MSCs) are an interesting candidate because of their immunosuppressive and regenerative properties. Of importance, no other clinical studies have investigated their effects in allograft rejection and fibrosis. We performed a safety and feasibility study in kidney allograft recipients to whom two intravenous infusions (1 million cells per kilogram) of autologous bone marrow (BM) MSCs were given, when a protocol renal biopsy at 4 weeks or 6 months showed signs of rejection and/or an increase in interstitial fibrosis/tubular atrophy (IF/TA). Six patients received MSC infusions. Clinical and immune monitoring was performed up to 24 weeks after MSC infusions. MSCs fulfilled the release criteria, infusions were well-tolerated, and no treatment-related serious adverse events were reported. In two recipients with allograft rejection, we had a clinical indication to perform surveillance biopsies and are able to report on the potential effects of MSCs in rejection. Although maintenance immunosuppression remained unaltered, there was a resolution of tubulitis without IF/TA in both patients. Additionally, three patients developed an opportunistic viral infection, and five of the six patients displayed a donor-specific downregulation of the peripheral blood mononuclear cell proliferation assay, not reported in patients without MSC treatment. Autologous BM MSC treatment in transplant recipients with subclinical rejection and IF/TA is clinically feasible and safe, and the findings are suggestive of systemic immunosuppression." @default.
• W2149285411 created "2016-06-24" @default.
• W2149285411 creator A5000465465 @default.
• W2149285411 creator A5001166940 @default.
• W2149285411 creator A5019013671 @default.
• W2149285411 creator A5020130906 @default.
• W2149285411 creator A5021544227 @default.
• W2149285411 creator A5024962117 @default.
• W2149285411 creator A5035752811 @default.
• W2149285411 creator A5045591880 @default.
• W2149285411 creator A5058384202 @default.
• W2149285411 creator A5065564105 @default.
• W2149285411 creator A5069641539 @default.
• W2149285411 creator A5077186159 @default.
• W2149285411 date "2013-01-24" @default.
• W2149285411 modified "2023-10-02" @default.
• W2149285411 title "Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study" @default.
• W2149285411 cites W1600258010 @default.
• W2149285411 cites W1973645636 @default.
• W2149285411 cites W1978370369 @default.
• W2149285411 cites W2000915212 @default.
• W2149285411 cites W2014582736 @default.
• W2149285411 cites W2016810249 @default.
• W2149285411 cites W2026598157 @default.
• W2149285411 cites W2043509877 @default.
• W2149285411 cites W2060437379 @default.
• W2149285411 cites W2072176858 @default.
• W2149285411 cites W2078752247 @default.
• W2149285411 cites W2090782974 @default.
• W2149285411 cites W2105734762 @default.
• W2149285411 cites W2107825659 @default.
• W2149285411 cites W2116086770 @default.
• W2149285411 cites W2136586552 @default.
• W2149285411 cites W2138620116 @default.
• W2149285411 cites W2167474540 @default.
• W2149285411 doi "https://doi.org/10.5966/sctm.2012-0114" @default.
• W2149285411 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3659754" @default.
• W2149285411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23349326" @default.
• W2149285411 hasPublicationYear "2013" @default.
• W2149285411 type Work @default.
• W2149285411 sameAs 2149285411 @default.
• W2149285411 citedByCount "265" @default.
• W2149285411 countsByYear W21492854112013 @default.
• W2149285411 countsByYear W21492854112014 @default.
• W2149285411 countsByYear W21492854112015 @default.
• W2149285411 countsByYear W21492854112016 @default.
• W2149285411 countsByYear W21492854112017 @default.
• W2149285411 countsByYear W21492854112018 @default.
• W2149285411 countsByYear W21492854112019 @default.
• W2149285411 countsByYear W21492854112020 @default.
• W2149285411 countsByYear W21492854112021 @default.
• W2149285411 countsByYear W21492854112022 @default.
• W2149285411 countsByYear W21492854112023 @default.
• W2149285411 crossrefType "journal-article" @default.
• W2149285411 hasAuthorship W2149285411A5000465465 @default.
• W2149285411 hasAuthorship W2149285411A5001166940 @default.
• W2149285411 hasAuthorship W2149285411A5019013671 @default.
• W2149285411 hasAuthorship W2149285411A5020130906 @default.
• W2149285411 hasAuthorship W2149285411A5021544227 @default.
• W2149285411 hasAuthorship W2149285411A5024962117 @default.
• W2149285411 hasAuthorship W2149285411A5035752811 @default.
• W2149285411 hasAuthorship W2149285411A5045591880 @default.
• W2149285411 hasAuthorship W2149285411A5058384202 @default.
• W2149285411 hasAuthorship W2149285411A5065564105 @default.
• W2149285411 hasAuthorship W2149285411A5069641539 @default.
• W2149285411 hasAuthorship W2149285411A5077186159 @default.
• W2149285411 hasBestOaLocation W21492854111 @default.
• W2149285411 hasConcept C126322002 @default.
• W2149285411 hasConcept C126894567 @default.
• W2149285411 hasConcept C128057223 @default.
• W2149285411 hasConcept C142724271 @default.
• W2149285411 hasConcept C198826908 @default.
• W2149285411 hasConcept C203014093 @default.
• W2149285411 hasConcept C2775934546 @default.
• W2149285411 hasConcept C2780007613 @default.
• W2149285411 hasConcept C2780252810 @default.
• W2149285411 hasConcept C2780559512 @default.
• W2149285411 hasConcept C2911091166 @default.
• W2149285411 hasConcept C71924100 @default.
• W2149285411 hasConceptScore W2149285411C126322002 @default.
• W2149285411 hasConceptScore W2149285411C126894567 @default.
• W2149285411 hasConceptScore W2149285411C128057223 @default.
• W2149285411 hasConceptScore W2149285411C142724271 @default.
• W2149285411 hasConceptScore W2149285411C198826908 @default.
• W2149285411 hasConceptScore W2149285411C203014093 @default.
• W2149285411 hasConceptScore W2149285411C2775934546 @default.
• W2149285411 hasConceptScore W2149285411C2780007613 @default.
• W2149285411 hasConceptScore W2149285411C2780252810 @default.
• W2149285411 hasConceptScore W2149285411C2780559512 @default.
• W2149285411 hasConceptScore W2149285411C2911091166 @default.
• W2149285411 hasConceptScore W2149285411C71924100 @default.
• W2149285411 hasIssue "2" @default.
• W2149285411 hasLocation W21492854111 @default.
• W2149285411 hasLocation W21492854112 @default.
• W2149285411 hasLocation W21492854113 @default.
• W2149285411 hasLocation W21492854114 @default.
• W2149285411 hasOpenAccess W2149285411 @default.
• W2149285411 hasPrimaryLocation W21492854111 @default.

• next